Frequency Therapeutics
Signal active
Organization
Contact Information
Overview
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering.
It was founded in 2015 and headquartered in Woburn, Massachusetts.
About
Industries
Biotechnology, Health Care, Medical, Genetics
Founded
2015
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Frequency Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Genetics sector. The company focuses on Biotechnology and has secured $15.1B in funding across 128 round(s). With a team of 51-100 employees, Frequency Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Frequency Therapeutics, raised $32.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
Funding Rounds
Funding rounds
8
Investors
7
Lead Investors
0
Total Funding Amount
$118.3M
Details
4
Frequency Therapeutics has raised a total of $118.3M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 42.0M | ||
| 2019 | Late Stage Venture | |||
| 2017 | Early Stage Venture | |||
| 2017 | Early Stage Venture | 32.0M |
Investors
Frequency Therapeutics is funded by 41 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Alexandria Real Estate Equities | - | FUNDING ROUND - Alexandria Real Estate Equities | 32.0M |
| Rivas Capital | - | FUNDING ROUND - Rivas Capital | 32.0M |
| Frequency Therapeutics | - | FUNDING ROUND - Frequency Therapeutics | 32.0M |
| PBJ Capital | - | FUNDING ROUND - PBJ Capital | 32.0M |
Recent Activity
There is no recent news or activity for this profile.